Cargando…

Nutraceuticals and Enteric Glial Cells

Until recently, glia were considered to be a structural support for neurons, however further investigations showed that glial cells are equally as important as neurons. Among many different types of glia, enteric glial cells (EGCs) found in the gastrointestinal tract, have been significantly underes...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Gómez, Laura, Szymaszkiewicz, Agata, Zielińska, Marta, Abalo, Raquel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234579/
https://www.ncbi.nlm.nih.gov/pubmed/34205534
http://dx.doi.org/10.3390/molecules26123762
_version_ 1783714116483940352
author López-Gómez, Laura
Szymaszkiewicz, Agata
Zielińska, Marta
Abalo, Raquel
author_facet López-Gómez, Laura
Szymaszkiewicz, Agata
Zielińska, Marta
Abalo, Raquel
author_sort López-Gómez, Laura
collection PubMed
description Until recently, glia were considered to be a structural support for neurons, however further investigations showed that glial cells are equally as important as neurons. Among many different types of glia, enteric glial cells (EGCs) found in the gastrointestinal tract, have been significantly underestimated, but proved to play an essential role in neuroprotection, immune system modulation and many other functions. They are also said to be remarkably altered in different physiopathological conditions. A nutraceutical is defined as any food substance or part of a food that provides medical or health benefits, including prevention and treatment of the disease. Following the description of these interesting peripheral glial cells and highlighting their role in physiological and pathological changes, this article reviews all the studies on the effects of nutraceuticals as modulators of their functions. Currently there are only a few studies available concerning the effects of nutraceuticals on EGCs. Most of them evaluated molecules with antioxidant properties in systemic conditions, whereas only a few studies have been performed using models of gastrointestinal disorders. Despite the scarcity of studies on the topic, all agree that nutraceuticals have the potential to be an interesting alternative in the prevention and/or treatment of enteric gliopathies (of systemic or local etiology) and their associated gastrointestinal conditions.
format Online
Article
Text
id pubmed-8234579
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82345792021-06-27 Nutraceuticals and Enteric Glial Cells López-Gómez, Laura Szymaszkiewicz, Agata Zielińska, Marta Abalo, Raquel Molecules Review Until recently, glia were considered to be a structural support for neurons, however further investigations showed that glial cells are equally as important as neurons. Among many different types of glia, enteric glial cells (EGCs) found in the gastrointestinal tract, have been significantly underestimated, but proved to play an essential role in neuroprotection, immune system modulation and many other functions. They are also said to be remarkably altered in different physiopathological conditions. A nutraceutical is defined as any food substance or part of a food that provides medical or health benefits, including prevention and treatment of the disease. Following the description of these interesting peripheral glial cells and highlighting their role in physiological and pathological changes, this article reviews all the studies on the effects of nutraceuticals as modulators of their functions. Currently there are only a few studies available concerning the effects of nutraceuticals on EGCs. Most of them evaluated molecules with antioxidant properties in systemic conditions, whereas only a few studies have been performed using models of gastrointestinal disorders. Despite the scarcity of studies on the topic, all agree that nutraceuticals have the potential to be an interesting alternative in the prevention and/or treatment of enteric gliopathies (of systemic or local etiology) and their associated gastrointestinal conditions. MDPI 2021-06-21 /pmc/articles/PMC8234579/ /pubmed/34205534 http://dx.doi.org/10.3390/molecules26123762 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
López-Gómez, Laura
Szymaszkiewicz, Agata
Zielińska, Marta
Abalo, Raquel
Nutraceuticals and Enteric Glial Cells
title Nutraceuticals and Enteric Glial Cells
title_full Nutraceuticals and Enteric Glial Cells
title_fullStr Nutraceuticals and Enteric Glial Cells
title_full_unstemmed Nutraceuticals and Enteric Glial Cells
title_short Nutraceuticals and Enteric Glial Cells
title_sort nutraceuticals and enteric glial cells
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234579/
https://www.ncbi.nlm.nih.gov/pubmed/34205534
http://dx.doi.org/10.3390/molecules26123762
work_keys_str_mv AT lopezgomezlaura nutraceuticalsandentericglialcells
AT szymaszkiewiczagata nutraceuticalsandentericglialcells
AT zielinskamarta nutraceuticalsandentericglialcells
AT abaloraquel nutraceuticalsandentericglialcells